Gilead Sciences to Buy Ouro Medicines, Collaborate With Galapagos on Purchased Assets Gilead Sciences plans to acquire Ouro Medicines for up to about $2.18 billion and develop the assets from the deal in a collaboration with Galapagos. Post navigation Previous Previous post: KB5085518 hotpatch fixes apps sign-in issues for Windows 11 25H2 and 24H2 enterprise usersNext Next post: I Tested Hyundai’s 2026 Palisade Calligraphy’s High-Tech Features: Here’s What’s Actually Useful Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. Related News Edge users are begging Microsoft to return these two features 0 Here are 40 of our favorite deals from REI’s massive Anniversary Sale 0
